GlassScriptPhysician profile
Fares Jamal
NPI 1538724166
$5,816.52
in general payments reported to CMS, 2019-2025
20 companies · $2,118 in 2025
The $2,118 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $2,905 · 2024: $642 · 2025: $2,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,147 · Travel and Lodging: $1,388 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,146.63 |
| Travel and Lodging | $1,387.63 |
| Education | $130.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,216.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $1,040.20 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $486.16 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $270.21 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.51 | 2023-2025 | Jardiance |
| Amgen INC. | $222.64 | 2023-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $207.59 | 2024-2025 | Uptravi, Opsumit |
| Irhythm Technologies, INC. | $189.30 | 2023 | Zio Xt Patch |
| Biosense Webster, INC. | $174.47 | 2024-2025 | Na, Carto 3 |
| Merck Sharp & Dohme LLC | $160.86 | 2023-2024 | Verquvo |
| Medtronic, INC. | $119.94 | 2022 | |
| Abiomed | $119.60 | 2023-2024 | Impella |
| Stryker Corporation | $74.55 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Chiesi USA, INC. | $63.73 | 2023-2025 | Kengreal, Cleviprex |
| Janssen Pharmaceuticals, INC | $59.49 | 2024 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $36.95 | 2023 | Glidewire, Angio-Seal |
| Pfizer INC. | $31.33 | 2022 | |
| Recor Medical INC | $24.76 | 2025 | Paradise Ultrasound Renal Denervation System |
| Heartflow, INC. | $24.67 | 2025 | |
| Getinge USA Sales, LLC | $24.33 | 2023 | Flixene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fares Jamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.